Clinical Trials, Inc. - Completed Studies

Navigation for Arkansas Clinical Trials
 
Indication Drug/Device Phase
Alzheimer's disease Cognishunt device III
Alzheimer's disease SGS742 II
Chronic Low Back Pain Tramadol undisclosed
Chronic Pain Tramadol undisclosed
Diabetes undisclosed undisclosed
Diabetic Neuropathy ABT-594 undisclosed
Diabetic Neuropathy Keppra undisclosed
Diabetic Neuropathy Lacosamide undisclosed
Diabetic Neuropathy Lacosamide III
Diabetic Neuropathy Lacosamide undisclosed
Diabetic Neuropathy Lamictal undisclosed
Diabetic Neuropathy Lamictal undisclosed
Diabetic Neuropathy Lamictal undisclosed
Diabetic Neuropathy Memantine undisclosed
Diabetic Neuropathy Pregabalin undisclosed
Diabetic Neuropathy Pregabalin undisclosed
Diabetic Neuropathy rhNGF undisclosed
Diabetic Neuropathy rhNGF undisclosed
Diabetic Neuropathy rhNGF undisclosed
Diabetic Neuropathy rhNGF undisclosed
Diabetic Neuropathy Topamax undisclosed
Epilepsy 534U87 undisclosed
Epilepsy 534U87 undisclosed
Epilepsy Depakote ER PK
Epilepsy Depakote ER PK
Epilepsy Felbatol undisclosed
Epilepsy Keppra undisclosed
Epilepsy Keppra undisclosed
Epilepsy Keppra undisclosed
Epilepsy Keppra undisclosed
Epilepsy Lacosamide II
Epilepsy Lacosamide II
Epilepsy Lacosamide III
Epilepsy Lacosamide undisclosed
Epilepsy Lamictal undisclosed
Epilepsy Lamictal undisclosed
Epilepsy Lamictal undisclosed
Epilepsy Lamictal undisclosed
Epilepsy Lamictal v. Topiramate IV
Epilepsy Losigamone undisclosed
Epilepsy Neurotin undisclosed
Epilepsy Pregabalin undisclosed
Epilepsy Pregabalin undisclosed
Epilepsy Pregabalin undisclosed
Epilepsy Pregabalin undisclosed
Epilepsy Remacemide undisclosed
Epilepsy Remacemide undisclosed
Epilepsy Retigabine undisclosed
Epilepsy Retigabine undisclosed
Epilepsy Retigabine undisclosed
Epilepsy Retigabine undisclosed
Epilepsy Rufinamide undisclosed
Epilepsy Rufinamide undisclosed
Epilepsy RWJ-333369 II a
Epilepsy RWJ-333369 II b
Epilepsy SB204269 undisclosed
Epilepsy SB204269 undisclosed
Epilepsy Seletracetam II a
Epilepsy Talampanel undisclosed
Epilepsy Talampanel undisclosed
Epilepsy Tiagabine undisclosed
Epilepsy Tiagabine undisclosed
Epilepsy Tiagabine undisclosed
Epilepsy Tiagabine undisclosed
Epilepsy Tiagabine undisclosed
Epilepsy Tiagabine undisclosed
Epilepsy Topamax undisclosed
Epilepsy Topamax undisclosed
Epilepsy Topamax undisclosed
Epilepsy Topamax undisclosed
Epilepsy Topamax undisclosed
Epilepsy Vigabatrin undisclosed
Epilepsy Vigabatrin undisclosed
Epilepsy Vigabatrin undisclosed
Epilepsy Vigabatrin undisclosed
Epilepsy VNS IV
Epilepsy-cognitive functioning Topamax undisclosed
Epilepsy-PGTC Lamictal undisclosed
Epilepsy-PGTC Rufinamide undisclosed
Epilepsy-PGTC Zonegran undisclosed
Epilepsy-partial Lamictal XR III
Multiple Sclerosis Campath II
Osteoarthritis Tramadol undisclosed
Parkinson's disease PARCOPA III
Parkinson's disease Ropinirole II
Parkinson's disease Ropinirole PK II
Parkinson's disease Sumanirole III
Parkinson's disease Sumanirole II
Parkinson's disease Sumanirole III
PHT Interaction Perprazole undisclosed

bar.jpg - 2116 Bytes

Clinical Trials, Inc.
Two Lile Court, Suite 100
Little Rock, Arkansas  72205
Ph:  501-227-6179
Fax:  501-221-3426
Info@clinicaltrialsinc.com

Home Page  |  What is a Clinical Trial  |  Studies Available  |  How Do I Participate
About Us  |  Contact Us  |  Privacy Statement  |  Related Links

Site Design:  Oxbow Creations Inc.